Jeffrey Jacobsen

709 total citations
10 papers, 502 citations indexed

About

Jeffrey Jacobsen is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Jeffrey Jacobsen has authored 10 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Genetics. Recurrent topics in Jeffrey Jacobsen's work include Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Jeffrey Jacobsen is often cited by papers focused on Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Jeffrey Jacobsen collaborates with scholars based in United States, Singapore and Canada. Jeffrey Jacobsen's co-authors include Megan S. McAfee, Pooja Hingorani, Dario Campana, Paul S. Dickman, Danielle M. Lussier, Joseph N. Blattman, Susan Holechek, William L. Roberts, Ashley M. Bunker and Hiroto Inaba and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Jeffrey Jacobsen

10 papers receiving 499 citations

Peers

Jeffrey Jacobsen
April Sorrell United States
CM Niemeyer United States
P.S. Mitrou Germany
C Béhar France
R. Schlenk Germany
April Sorrell United States
Jeffrey Jacobsen
Citations per year, relative to Jeffrey Jacobsen Jeffrey Jacobsen (= 1×) peers April Sorrell

Countries citing papers authored by Jeffrey Jacobsen

Since Specialization
Citations

This map shows the geographic impact of Jeffrey Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Jacobsen more than expected).

Fields of papers citing papers by Jeffrey Jacobsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Jacobsen. The network helps show where Jeffrey Jacobsen may publish in the future.

Co-authorship network of co-authors of Jeffrey Jacobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Jacobsen. A scholar is included among the top collaborators of Jeffrey Jacobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Jacobsen. Jeffrey Jacobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schafernak, Kristian T., Jeffrey Jacobsen, Dulce María Hernández Hernández, Robin Kaye, & Sylvia E. Perez. (2021). Cytochemical Characterization of Cerebrospinal Fluid Macrophage Inclusions in Pediatric Patients Receiving Intrathecal Nusinersen (SPINRAZA®) for Spinal Muscular Atrophy. Acta Cytologica. 66(1). 79–84. 4 indexed citations
2.
Tvrdik, Tatiana, Kristian T. Schafernak, Jeffrey Jacobsen, et al.. (2019). Clinical and Cytogenomic Features of Lymphoblastic Leukemia with Intrachromosomal Amplification of Chromosome 21 (iAMP21) in the Context of Constitutional Ring Chromosome 21. Blood. 134(Supplement_1). 5208–5208. 1 indexed citations
3.
Lussier, Danielle M., Megan S. McAfee, Susan Holechek, et al.. (2015). Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions. Journal of Immunotherapy. 38(3). 96–106. 165 indexed citations
4.
Srinivasan, Ashok, John C. Panetta, Shane J. Cross, et al.. (2014). Phase I Study of the Safety and Pharmacokinetics of Plerixafor in Children Undergoing a Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Leukemia. Biology of Blood and Marrow Transplantation. 20(8). 1224–1228. 10 indexed citations
5.
Jeha, Sima, Elaine Coustan‐Smith, Deqing Pei, et al.. (2014). Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome‐positive acute lymphoblastic leukemia. Cancer. 120(10). 1514–1519. 50 indexed citations
6.
Inaba, Hiroto, Elaine Coustan‐Smith, Xueyuan Cao, et al.. (2012). Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia. Journal of Clinical Oncology. 30(29). 3625–3632. 136 indexed citations
7.
Smith, Lynette M., James R. Anderson, Minnie Abromowitch, et al.. (2012). The immunophenotype of T ‐lymphoblastic lymphoma in children and adolescents: a C hildren's O ncology G roup report. British Journal of Haematology. 159(4). 454–461. 69 indexed citations
8.
Salama, Mohamed E., et al.. (2012). Congenital and Childhood myeloproliferative disorders with eosinophilia responsive to imatinib. Pediatric Blood & Cancer. 59(5). 928–929. 10 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026